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BACKGROUND: Animal studies suggest that phthalates and bisphenol A (BPA), endocrine-disrupting chemicals found in many consumer products,
may impact the timing of puberty.
OBJECTIVES:We aimed to determine the association of prenatal exposure to high-molecular-weight phthalates and BPA with pubertal timing in boys
and girls participating in the Center for the Health Assessment of Mothers and Children of Salinas (CHAMACOS) longitudinal cohort study.
METHODS: We quantified urinary concentrations of eight phthalate metabolites and BPA at two time points during pregnancy among participating
mothers (n=338) and conducted clinical Tanner staging of puberty on their children every 9 months between 9 and 13 y of age. We conducted accel-
erated failure time models and examined the role of child overweight/obese status in this association.
RESULTS: The sum of urinary metabolites of di(2-ethylhexyl) phthalate ðPDEHPÞ, monobenzyl phthalate (MBzP), and BPA were associated with
later onset of at least one of the three outcomes assessed in girls (thelarche, pubarche, or menarche) and with earlier onset of at least one of the two
outcomes assessed in boys (gondarche and pubarche). We found that monocarboxynonyl phthalate, monocarboxyoctyl phthalate, mono
(3-carboxypropyl) phthalate, and BPA were associated with later pubarche and menarche mostly among normal-weight girls but not overweight/obese
girls. MBzP was associated with later thelarche in all girls, and
P
DEHP was associated with later thelarche and menarche in all girls. BPA and all
phthalate biomarkers were associated with earlier gonadarche and pubarche in all boys as well as in overweight/obese boys when stratified by weight.
Among normal-weight boys, associations with BPA were also inverse, whereas associations with phthalate metabolites were close to the null or
positive.
CONCLUSIONS: Several high-molecular-weight phthalates and BPA were associated with later puberty in girls and earlier puberty in boys included in
the CHAMACOS cohort study. Childhood overweight/obesity may modify these associations. https://doi.org/10.1289/EHP3424
Introduction
Recent trends suggest that girls are entering puberty at earlier
ages and that pubertal timing may be altered in boys as well
(Euling et al. 2008; Papadimitriou 2016). Hypothesized causes of
these changes in pubertal timing include the increasing preva-
lence of childhood obesity and exposure to environmental chemi-
cals (Biro and Kiess 2016; Toppari and Juul 2010). Several
chemicals used in plastics have been identified as potential endo-
crine disruptors, which may impact reproductive development
and pubertal timing. Phthalates are chemicals used to soften
plastics (e.g., polyvinyl chloride) and are widely used in build-
ing materials, medical devices, food packaging, and other con-
sumer items. High-molecular-weight (HMW) phthalates used
as plasticizers include butylbenzyl phthalate (BBzP), di(2-
ethylhexyl) phthalate (DEHP), diisononyl phthalate (DiNP),
and diisodecyl phthalate (DiDP). Bisphenol A (BPA) is a chem-
ical used in the manufacture of certain hard plastics, such as
polycarbonate, which is used in a large variety of products
including some food storage containers and water bottles. BPA
is also used in dental sealants and some paper receipts. Exposure
to phthalates and BPA is nearly ubiquitous. Most HMW phthalate
metabolites were detected in >98% and BPA was detected in 96%
of the 2013–2014 participants in the National Health and Nutrition
Examination Survey (NHANES) (CDC 2013–2014).
Animal studies have shown that in utero or early life exposure
to the phthalate DEHP is associated with earlier ovarian develop-
ment (Wang et al. 2016) and estrous (Ma et al. 2006) in female
rats and either earlier (Ge et al. 2007) or later (Ge et al. 2007;
Noriega et al. 2009) pubertal onset in male rats, depending on
dose. Similarly, BPA has been associated with earlier age at vagi-
nal opening (Howdeshell et al. 1999; Losa-Ward et al. 2012; Nah
et al. 2011; Yang et al. 2014), a marker of female puberty in rats,
but with later age at preputial separation (Tan et al. 2003), a
marker of male puberty in rats. To date, most animal studies have
focused on DEHP and BPA, with few studies examining the
other HMW phthalates. DEHP and other HMW phthalates have
exhibited anti-androgenic properties (Gray et al. 2000), whereas
BPA has shown estrogenic properties (Rubin 2011). The trends
seen in animal studies of earlier puberty in females and later pu-
berty in males are consistent with exposure to anti-androgenic or
estrogenic compounds.
Cross-sectional studies in children have shown higher levels
of DEHP in the blood of girls with precocious puberty (Lu et al.
2006) and higher concentrations of DEHP metabolites in the
urine of boys with delayed puberty (Xie et al. 2015). A study that
followed 430 children for 1.5 y at 6–13 y of age found that uri-
nary concentrations of DEHP metabolites at baseline were associ-
ated with earlier age at menarche and breast development in girls
(Zhang et al. 2015). However, several other cross-sectional stud-
ies have found no associations of HMW phthalates and timing of
puberty in girls (Buttke et al. 2012; Chou et al. 2009; Frederiksen
et al. 2012; Hou et al. 2015) or boys (Hou et al. 2015). BPA has
also been associated with early breast development and menarche
in two cross-sectional studies (Chen et al. 2015; McGuinn et al.
Address correspondence to K.G. Harley, Center for Environmental Research
and Children’s Health (CERCH), School of Public Health, University of
California, Berkeley, 1995 University Ave., Suite 265, Berkeley, CA 94704
USA. Telephone: (510) 643-1310. Email: kharley@berkeley.edu
Supplemental Material is available online (https://doi.org/10.1289/EHP3424).
The authors declare they have no actual or potential competing financial
interests.
Received 30 January 2018; Revised 12 July 2018; Accepted 2 August 2018;
Published 11 September 2018.
Note to readers with disabilities: EHP strives to ensure that all journal
content is accessible to all readers. However, some figures and Supplemental
Material published in EHP articles may not conform to 508 standards due to
the complexity of the information being presented. If you need assistance
accessing journal content, please contact ehponline@niehs.nih.gov. Our staff
will work with you to assess and meet your accessibility needs within
3 working days.
Environmental Health Perspectives 097004-1 126(9) September 2018
A Section 508–conformant HTML version of this article
is available at https://doi.org/10.1289/EHP3424.Research
2015) and with earlier genital and pubic hair development in
boys in one study (Wang et al. 2017). However, cross-sectional
studies are not able to measure exposure prior to the onset of pu-
berty and cannot examine exposure in utero or in early childhood,
which may be critical time periods during which children are par-
ticularly susceptible to the endocrine-disrupting effects of these
plasticizing compounds.
Early life exposure to HMW phthalates and BPA was exam-
ined in a small number of longitudinal human studies and no
associations between exposure to phthalates and puberty in boys
were found (Ferguson et al. 2014; Kasper-Sonnenberg et al.
2017; Zhang et al. 2015) and few associations of BPA and pu-
berty in boys or girls (Ferguson et al. 2014; Watkins et al. 2014;
Wolff et al. 2017). However, associations of HMW phthalates
and altered pubertal timing in girls were reported in three studies
(Kasper-Sonnenberg et al. 2017; Watkins et al. 2014; Wolff et al.
2017). The multicenter Breast Cancer and the Environment
Research Program (BCERP) followed 1,015 American girls
for 9–11 y and found that urinary concentrations of mono(3-
carboxypropyl) phthalate (MCPP), a metabolite of several HMW
phthalates, measured between 6 and 8 y of age was associated
with later age at menarche and breast development; no associa-
tions were seen with BPA or other HMW phthalates (Wolff et al.
2014, 2017). This finding was strongest in girls who were not
overweight or obese. In the Early Life Exposure in Mexico to
Environmental Toxicants (ELEMENT) study, a longitudinal birth
cohort study in Mexico City and the only study to analyze in
utero phthalates and puberty, mothers’ prenatal urinary concen-
trations of mono(2-ethylhexyl) phthalate (MEHP), a metabolite
of DEHP, were associated with earlier age at pubic hair develop-
ment in their daughters at 8–13 y of age (Watkins et al. 2014). A
study in Germany of 472 children followed once annually for 3 y
from 8 to 10 y of age found that prepubertal urinary concentra-
tions of MEHP and BPA were associated with delayed puberty
(Kasper-Sonnenberg et al. 2017).
In this study, we examined the association between prenatal
urinary concentrations of HMW phthalates and BPA in mothers
with the timing of breast development, pubic hair development,
and menarche in their daughters or with genital and pubic hair
development in their sons, assessed between 9 and 13 y of age.
We hypothesized that child overweight/obese status may mod-
ify this relationship. We also hypothesized that prenatal expo-
sure to these compounds may represent a critical window of
exposure for pubertal outcomes because of the influence these
chemicals may have on the in utero development of neuroendo-
crine systems.
Methods
Study Population
The Center for the Health Assessment of Mothers and Children
of Salinas (CHAMACOS) is a longitudinal cohort study examin-
ing the effects of in utero and childhood environmental exposures
on children’s growth, neurodevelopment, respiratory disease, and
pubertal development and has been described elsewhere (Harley
et al. 2013). The study is based in the Salinas Valley in
California, an agricultural community with a large Latino farm-
worker population. In 1999–2000, English or Spanish-speaking
pregnant women who were at <20weeks’ gestation, eligible for
low-income health insurance (Medicaid), and at least 18 y of age
were recruited from prenatal care clinics serving the Salinas
Valley’s farmworker population. We enrolled 601 pregnant
mothers, 537 of whom remained in the study through a live-born
delivery. Children were assessed at multiple time points in child-
hood. Stage of pubertal development was assessed beginning at
the 9-y-of-age visit and conducted every 9 months until 13 y
of age. At least one pubertal timing assessment and one in utero
urinary chemical measurement was available for 338 children (159
boys and 179 girls). All study activities were approved by the insti-
tutional review board (IRB) of the University of California,
Berkeley. Informed consent was obtained from mothers and assent
was obtained from children. Participation of human subjects did
not occur until after informed consent was obtained.
Quantification of Phthalate Metabolites and BPA
Mothers were interviewed and provided urine samples twice dur-
ing pregnancy (mean: 14.0 and 26.9 weeks’ gestation, average
sample collection interval: 90 d). Urine samples were collected in
polypropylene containers and then aliquoted into glass vials.
Samples were frozen at −80C until shipment on dry ice to the
Centers for Disease Control and Prevention for chemical analysis.
Monoester metabolites of HMW phthalates in prenatal urine
were quantified using solid-phase extraction coupled with isotope
dilution high-performance liquid chromatography–electrospray
ionization–tandem mass spectrometry (HPLC-ES-MS/MS). We
measured eight metabolites of four parent compounds: monoben-
zyl phthalate (MBzP, a metabolite of BBzP); four metabolites of
DEHP [mono(2-ethylhexyl) phthalate (MEHP), mono(2-ethyl-5-
hydroxyhexyl) phthalate (MEHHP), mono(2-ethyl-5-oxohexyl)
phthalate (MEOHP), and mono(2-ethyl-5-carboxypentyl) phthal-
ate (MECCP)]; monocarboxyoctyl phthalate (MCOP; a meta-
bolite of DiNP); monocarboxynonyl phthalate (MCNP; a metabo-
lite of DiDP); and mono(3-carboxypropyl) phthalate (MCPP; a
metabolite of several HMW phthalates and a minor metabolite of
dibutyl phthalate). BPA concentrations were quantified in prenatal
urine using isotope dilution online solid-phase extraction coupled
to HPLC-MS/MS. BPA, but not phthalate metabolites, was also
measured in child urine collected at 9 y of age. Analytic methods
have been published previously for both phthalates (Silva et al.
2007) and BPA (Ye et al. 2005). Chemical concentrations were
reported in nanograms per milliliter of urine. Limits of detection
(LODs) ranged from 0:2 to 0:5 ng=mL. Concentrations below the
LOD were assigned the instrumental reading values, if available,
or an imputed value below the LOD selected randomly from the
log-normal distribution using maximum likelihood estimation
(Lubin et al. 2004). We chose to present HMW phthalates and
BPA together in this paper because they come from similar sources
(mainly plastics).
Urinary specific gravity was measured using a hand-held re-
fractometer (National Instrument Company Inc.). We corrected
for urinary dilution using the formula: ðanalyte concentration ×
0:024Þ=ðsample specific gravity−1Þ (Mahalingaiah et al. 2008).
For 77 women who were missing specific gravity measurements,
urinary specific gravity was imputed based on urinary creatinine
concentrations.
Pubertal Assessment
Six trained research assistants assessed pubertal timing in the
children every 9 months between 9 and 13 y of age (i.e., at 9,
93 4= , 101 2= , 111 4= , 12, and 123 4 y of age= ) using clinical Tanner
staging (Tanner 1986). We assessed girls’ breast development
[ranging from B1 (prepubertal) to B5 (adult)], using palpation
and pubic hair development (ranging from PH1 to PH5), using
visual inspection. Although clinical Tanner staging did not begin
until 9 y of age, we obtained a maternal report of Tanner stage
for girls at 7 y of age. Menarche status was asked at each visit
and age at menarche was ascertained at the first post-menarchal
visit. We assessed boys’ stages of genital development (G1–G5)
and pubic hair development (PH1–PH5) visually and measured
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testicular volume (TV) using orchidometer beads as comparisons.
A boy was not considered to be in Stage G2 if his TV was
≤3 cm3. Pubertal onset was defined as reaching Stage 2 for breast
development (thelarche), pubic hair development (pubarche), or
genital development (gonadarche). Two pediatric endocrinolo-
gists trained and supervised the research assistants. Kappas for
their inter-rater reliability in girls were 0.70 for breast and 0.79
for pubic hair development, and in boys were 0.75 for genital and
0.86 for pubic hair development. With regard to whether the child
was in Stage 1 versus Stage 2 or higher, the examiners’ assess-
ments agreed with the pediatric endocrinologists’ assessments
90% and 92% of the time for girls’ breast and pubic hair stage,
respectively, and 92% and 100% of the time for boys’ genital and
pubic hair stage, respectively.
Covariate Data Collection
Covariate information was gathered from maternal interviews
conducted twice during pregnancy and when their children were
7, 9, 101 2= , and 12 y of age. Interviews were administered in ei-
ther English or Spanish using a structured questionnaire. Data on
maternal race/ethnicity, age at menarche, education, prepreg-
nancy body mass index (BMI) [calculated as weight=height2
(kg=m2)], the length of time lived in the United States, household
income, and age at pregnancy were collected at the first interview
during pregnancy. At the second pregnancy interview, mothers
answered an interviewer-administered food frequency question-
naire, based on the Spanish-language Block 98 Questionnaire
(Block et al. 1992) but adapted for this population. To classify
the overall quality of mothers’ diets, a Diet Quality Index for
Pregnancy based on several dietary characteristics was created
from the food frequency questionnaire (Bodnar and Siega-Riz
2002). Higher scores on this scale correspond to higher-quality
diets, with 80 as the maximum score. Child weight (Tanita TBF
300A bioimpedence scale) and height (Seca 222 stadiometer)
were measured to calculate BMI and children were classified as
underweight, normal, overweight, or obese at each visit based on
CDC percentile guidelines (Whitlock et al. 2005). We used the
9-y-of-age BMI for the effect modifier analyses to be concurrent
with the first puberty time point, and the 7-y-of-age data for the
mediation analyses to ensure that the BMI measurement preceded
the onset of puberty. For analysis, we categorized children using
a binary variable of normal weight versus overweight/obese. No
children were underweight at 7 y of age and only one child was
underweight at 9 y of age; this child was included in the
normal-weight category. At the 9-y-of-age visit, mothers were
asked about household income and the number of household
members to calculate family income as a proportion of the fed-
eral poverty threshold.
Statistical Analysis
We estimated prenatal chemical exposure as the average of the
two specific gravity–corrected, urinary biomarker concentrations
measured during pregnancy. We examined average biomarker con-
centrations as continuous (log2-transformed) and categorical (quar-
tiles) variables. Continuous concentrations were log-normally
distributed and were log2-transformed to reduce the leverage of
influentially high points. We examined DEHP as the molar sum of
the four DEHP metabolites: MEHP, MEHHP, MEOHP, and
MECPP ðPDEHPÞ. Other urinary biomarkers were examined
individually.
We conducted parametric accelerated failure time (AFT)
models, assuming a two-parameter Weibull distribution, to deter-
mine associations of urinary analytes with time to pubertal onset
using the Stata intcens program, which permits interval censoring
(i.e., pubertal onset occurring at an unknown time between two
study visits) in addition to left censoring (i.e., pubertal onset
occurring before the start of the observation period). Left censor-
ing among girls at 9 y of age was addressed by referring to the
mother-reported Tanner stage at 7 y of age. If mothers reported
that their daughters were in Stage 1 at 7 y of age (n=3 for breast
development and 3 for pubic hair development), pubertal onset
was assumed to have occurred between 7 and 9 y of age. If she
reported Stage 2 or higher at 7 y of age (n=19 for breast devel-
opment and 1 for girls’ pubic hair development), onset was
assumed to have occurred between 5 and 7 y of age. There was
no left censoring for boys. The AFT models produce time ratios
(TRs), which we converted into mean shift (in months) at
pubertal onset with each doubling of chemical exposure by
multiplying the TRs by the median age when children reached
each pubertal milestone (thelarche, pubarche, gonadarche, men-
arche). Median ages at thelarche, pubarche, and gonadarche for
the study population were calculated using an unadjusted AFT
model.
Covariates were selected a priori using directed acyclic
graphs (Textor et al. 2011) (see Figure S1) and included maternal
education, maternal years in United States, family income, diet
quality during pregnancy, and maternal prepregnancy BMI. We
controlled for diet quality during pregnancy because diet is an
important source of both phthalate and BPA exposure and may
be related to puberty timing through child weight (Colacino et al.
2010; Schecter et al. 2010; Zota et al. 2016). AFT models and
Paramed models were conducted only on individuals with com-
plete covariate data.
Because child BMI is a risk factor for early puberty (Ahmed
et al. 2009; Marcovecchio and Chiarelli 2013), we conducted
several sensitivity analyses to examine the role of child over-
weight/obese status on the associations of prenatal phthalate
and BPA exposure and timing of puberty. We have previously
reported associations between prenatal phthalate and BPA con-
centrations and childhood overweight/obese status in this
cohort (Harley et al. 2013, 2017). We did not include child
overweight/obesity status at 7 y of age as a covariate in the
main models because it may be on the causal pathway, but we
did include it in the sensitivity analyses to see whether results
changed substantially from those of the main models, possibly
reflecting mediation. We further examined mediation using the
Paramed package in Stata (Emsley and Liu 2013; VanderWeele
and Vansteelandt 2009) with binary chemical exposure variables
(above or below the median) and binary overweight/obese status at
7 y of age as the mediator. The Paramed models required the fol-
lowing assumptions: that there was no uncontrolled confounding
between the exposure and outcome, between the mediator and out-
come, or between the exposure and mediator, and that none of the
mediator–outcome confounders were affected by the exposures.
Paramed performed two linear regressions: one regressing over-
weight/obesity status at 7 y of age on prenatal chemical exposure
and covariates, and one regressing age at pubertal onset on both
overweight/obese status at 7 y of age and prenatal chemical expo-
sure and covariates. From these regressions, it estimated the natural
direct and indirect effects. Although there is an option to include
exposure–mediator interactions, we chose not to evaluate this.
Coefficients from Paramed models represent mean shift in years at
pubertal onset with above-median exposure. We also hypothesized
that child overweight/obesity status might be an effect modifier
based on results from previous studies (Wolff et al. 2017) and con-
ducted additional AFT models that included interaction terms
(log2 biomarker concentrations × overweight=obese status, consid-
ered significant at p<0:10) and additional AFT models stratified
by overweight/obese status at 9 y of age.
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Results
The study sample at 9 y of age comprised 179 girls (53%) and
159 boys (47%) (Table 1). Most mothers in this population were
Latina (98.5%) and had not graduated from high school (79%).
At the time of their pregnancies, mothers tended to be overweight
or obese (65%), to have lived in the United States for ≤10 y
(73%), and to be <30 y of age (74%). Most mothers had reached
menarche between 12 and 13 y of age (49%), with 31% reaching
menarche after 13 y of age. Most children were living below the
federal poverty index at 9 y of age (69%), and most children were
overweight or obese at 7 (53%) and 9 y of age (55%).
Most chemical biomarkers of interest were detected in over
90% of mothers during pregnancy (Table 2). Prenatal urine sam-
ples in this study were collected in 1999 and 2000. Compared with
NHANES participants in the closest years to when our data
was collected (1999–2000 for phthalates, 2003–2004 for BPA),
CHAMACOS participants had lower geometric means and 50th
percentiles of all chemicals (CDC 2015). Chemicals were moder-
ately to highly correlated, with Pearson’s r ranging from 0.36
(MCNP and
P
DEHP) to 0.73 (MCNP and MCOP). On average,
26-week samples were 15.3% lower than baseline samples (MBzP,
0.9% lower; MCNP, 16.1% lower; MCOP, 12.3% lower; MCPP,
17.7% lower; DEHP, 1.0% higher; and BPA, 46.0% lower).
By the start of the observation period (at 9 y of age), 39% of
girls had reached thelarche and 20% of girls had reached pubarche
(Table 3). The median ages in years at pubertal milestones were
for girls: 9.22 at thelarche, 10.31 at pubarche, and 11.67 at men-
arche, and for boys: 10.79 at gonadarche and 12.18 at pubarche.
When we examined all girls or all boys, without accounting for
overweight/obesity status at 9 y of age, several HMW phthalates
and BPA were associated with later puberty in girls (Table 4) and
earlier puberty in boys (Table 5). Specifically, in girls, MBzP
[mean shift for every doubling of MBzP urinary concentration=
1:9months; 95% confidence interval (CI): 0.2, 3.6],
P
DEHP
(mean shift = 2:5 months; 95% CI: 0.7, 4.3), and BPA (mean
shift = 3:0 months; 95% CI: 0.9, 5.1) were associated with later
thelarche.
P
DEHP was also associated with later menarche
(mean shift = 2:5months; 95% CI: 1.1, 4.1). In boys, BPA and all
phthalates except for
P
DEHP were associated with earlier gona-
darche, and MCOP (mean shift = − 2:4months; 95% CI: −4:6,
−0:3), MCPP (mean shift = − 2:0months; 95% CI: −3:8, −0:1),
and BPA (mean shift = − 3:1months; 95% CI: −5:1, −1:0) were
associated with earlier pubarche.
Most metabolites were associated with later menarche in
normal-weight girls (Table 4), including MCNP (mean shift =
2:4months; 95% CI: 0.4, 4.3), MCOP (mean shift = 2:1months;
95% CI: 0.1, 4.2), MCPP (mean shift = 3:3months; 95% CI: 1.3,
5.3),
P
DEHP (mean shift = 2:7months; 95% CI: 0.7, 4.6), and
BPA (mean shift = 3:2months; 95% CI: 1.1, 5.3). Only
P
DEHP
concentrations were also associated with later menarche in over-
weight/obese girls (mean shift = 3:2months; 95% CI: 0.9, 5.5).
MCOP (mean shift = 2:4months; 95% CI: 0.4, 4.5) and BPA
(mean shift = 4:0months; 95% CI: 1.3, 6.7) were associated with
later pubarche in normal-weight girls only. MCPP (mean shift =
2:3months; 95% CI: 0.1, 4.6) and BPA (mean shift = 4:7months;
95% CI: 2.5, 7.0) were associated with later thelarche in normal-
weight girls only, whereas MBzP and
P
DEHP were associated
with later thelarche in both weight categories. In interaction mod-
els, cross-product terms for metabolites × overweight=obese
status at 9 y of age were significant for many of the associations
(Table 4).
Table 5 shows that associations with earlier puberty in boys
were largely seen only among those who were overweight/obese
at 9 y of age. We observed associations of all phthalates and BPA
with earlier gonadarche and pubarche among overweight/obese
boys. In contrast, the only associations observed among normal-
weight boys were with BPA and earlier gonadarche (mean shift of
−5:0 months; 95% CI: −9:1, −0:6) and MBzP and later pubarche
(mean shift = 3.5 month; 95% CI: 0.4, 6.5). Interaction terms for
overweight/obese status at 9 y of age were significant for most
associations.
In the sensitivity analyses, we tested for mediation by over-
weight/obese status at 7 y of age. When we added overweight/
obese status at 7 y of age as a covariate to the main models shown
Table 1. Characteristics of 338 children in the CHAMACOS cohort, Salinas,
California.
Characteristics n Percentage (%)
Child’s sex
Female 179 53.0
Male 159 47.0
Mother’s race/ethnicity
Latina 333 98.5
Non-Hispanic white 2 0.6
Other 3 0.9
Mother’s age at menarche (y)
<12 67 19.8
12–13 165 48.8
>13 106 31.4
Mother’s educational attainment during
pregnancy
≤6th grade 150 44.4
7–12th grade 117 34.6
High school graduate 71 21.0
Maternal prepregnancy BMI
Underweight 2 0.6
Normal weight 115 34.0
Overweight 131 38.8
Obese 90 26.6
Mother’s years of residence in the United States
during pregnancy (y)
≤1 72 21.3
2–5 89 26.3
6–10 86 25.4
≥11 56 16.6
Entire life 35 10.4
Mother’s age at delivery (y)
18–24 137 40.5
2–29 113 33.4
3–34 55 16.3
3–45 33 9.8
Diet Quality Index during Pregnancy, by quantiles
(mean score)
Quantile 1, 33.2 84 24.9
Quantile 2, 41.9 80 23.7
Quantile 3, 48.6 77 22.8
Quantile 4, 57.8 78 23.1
Missing 19 5.6
Family income at 9 y of age
≤100% federal poverty level 231 68.3
>100% federal poverty level 105 31.1
Missing 2 0.6
Child’s overweight status at 9 y of age
Underweight 1 0.3
Normal weight 144 42.6
Overweight 54 15.9
Obese 125 37.0
Missing 14 4.1
Child’s overweight status at 7 y of age
Underweight 0 0.0
Normal weight 151 44.4
Overweight 61 17.9
Obese 112 32.9
Missing 16 4.7
Note: BMI, body mass index; CHAMACOS, Center for the Health Assessment of
Mothers and Children of Salinas.
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in Tables 4 and 5, all significant associations for boys were atte-
nuated (see Table S1), suggesting that BMI may be on the causal
pathway between prenatal phthalate or BPA exposure and earlier
puberty in boys. In girls, some associations were attenuated,
whereas others became stronger (see Table S1). However, using
the mediation models (Paramed package), we observed estimates
of natural direct effects for many chemicals but little evidence of
estimates of indirect effects, suggesting that mediation by over-
weight/obese status at 7 y of age is not a strong factor (see Table
S2). We did not detect any significant estimates of indirect effects
via overweight/obesity status at 7 y of age for boys and only one
significant estimate of a natural indirect effect for girls, with
MCNP and thelarche in the direction of earlier puberty, suggest-
ing that mediation largely did not explain the observed interaction
by overweight/obesity status at 9 y of age. However, these esti-
mates are only valid if the underlying assumptions (that there
was no uncontrolled confounding between the exposure and out-
come, between the mediator and outcome, or between the expo-
sure and mediator, and that none of the mediator–outcome
confounders were affected by the exposures), which cannot be
verified, hold.
Discussion
We found that prenatal concentrations of urinary biomarkers of
certain HMW phthalates and BPA were associated with later pu-
berty in girls and earlier puberty in boys. These associations dif-
fered by childhood overweight/obese status at 9 y of age, such
that stronger associations of later puberty were generally seen
among normal-weight girls and those of earlier puberty were
seen among overweight/obese boys. The exception in boys was
BPA, which was associated with earlier gonadarche in both
normal-weight and overweight/obese boys. In girls, exceptions
were
P
DEHP, which was associated with later puberty in both
categories, and MBzP, which was associated with later puberty
only in overweight/obese girls.
Despite differences by overweight/obese status at 9 y of age,
associations were consistently in the direction of later puberty for
girls and earlier puberty for boys. This does not support our origi-
nal hypothesis that these chemicals would be associated with
earlier puberty in girls, and it does not help explain the recent
global trend towards earlier puberty in girls (Euling et al. 2008;
Papadimitriou 2016). These findings also are not supported by the
animal literature that suggests that early life exposure to DEHP
and BPA leads to earlier female puberty (Howdeshell et al. 1999;
Losa-Ward et al. 2012; Ma et al. 2006; Nah et al. 2011; Wang et al.
2016; Yang et al. 2014) and later male puberty (Noriega et al.
2009; Tan et al. 2003), which is consistent with estrogenic or anti-
androgenic mechanisms.
However, our findings are somewhat consistent with those of
the BCERP study, which found associations of several HMW
phthalates with later puberty in girls (Wolff et al. 2010, 2014,
2017). Although specific findings differ between the two studies
(the BCERP study found that early childhood concentrations of
MBzP and
P
DEHP were associated with later pubarche and
MCPP with later thelarche and menarche), that study, like ours,
observed interaction by BMI, with associations with later puberty
being strongest in girls with normal (<70th percentile) BMI.
Similarly, the study by Kasper-Sonnenberg et al. (2017) in
Germany also found that urinary concentrations of MEHP and
BPA were associated with later self-reported puberty in girls.
That study controlled for BMI in its models but did not analyze
interaction by BMI. However, the ELEMENT study, which is the
only other study to examine in utero urinary biomarkers, found
that prenatal metabolites of DEHP (specifically MEHP) were
associated with earlier pubarche in girls, unlike in our study
(Watkins et al. 2014). The ELEMENT study did not examine
interaction by BMI.
However, there are also several inconsistencies with other
longitudinal studies. Neither the BCERP nor ELEMENT stud-
ies found any associations of BPA concentrations with timing
of puberty in girls (Watkins et al. 2014; Wolff et al. 2015), and
the ELEMENT study found no association of in utero phthalate
and BPA concentrations with pubertal timing in boys (Ferguson
et al. 2014). The Puberty Timing and Health Effects in Chinese
Children study found urinary DEHP metabolites to be associ-
ated with earlier puberty onset in 208 girls, but no phthalate
metabolites were associated with pubertal timing in 222 boys
(Zhang et al. 2015). However, that study measured phthalate
metabolites and BPA in childhood, studied children over a wide
age range (6–13 y), and only followed them for 1.5 y and there-
fore is limited by many of the same weaknesses of cross-
sectional studies.
Few studies other than ours and the BCERP study have exam-
ined how child weight modifies the association of phthalates,
Table 2. Distribution of urinary concentrations of high-molecular-weight phthalates and BPA (average of two urine samples collected during pregnancy).
Biomarker (ng=mL) LOD (ng=mL) Percent of samples >LOD (%) Geometric mean (ng=mL)
Percentiles
10th 25th 50th 75th 90th 95th
MBzP 0.3 98.1 9.0 2.5 4.9 9.2 18.3 29.4 40.6
MCNP 0.2 95.8 2.3 0.9 1.5 2.3 3.5 5.4 7.6
MCOP 0.2 96.4 3.8 1.5 2.4 3.8 5.6 8.9 12.2
MCPP 0.2 91.1 2.2 0.8 1.4 2.4 3.8 5.3 7.2
MEHPa 0.5 89.9 4.4 1.4 2.6 4.4 7.6 14.4 19.3
MEHHPa 0.2 99.5 18.4 6.6 10.9 17.8 32.1 49.4 72.1
MEOHPa 0.2 98.3 13.4 5.2 7.7 13.6 21.4 38.4 47.5
MECPPa 0.2 100.0 31.6 13.6 20.7 30.1 47.0 75.6 98.7
BPA 0.4 85.7 1.5 0.6 0.9 1.3 2.3 3.7 5.8
Note: All values are specific gravity corrected. BPA, bisphenol A; LOD, limit of detection; MBzP, monobenzyl phthalate; MCNP, monocarboxynonyl phthalate; MCOP, monocarbox-
yoctyl phthalate; MCPP, mono(3-carboxypropyl) phthalate; MECPP, mono(2-ethyl-5-carboxypentyl) phthalate; MEHHP, mono(2-ethyl-5-hydroxyhexyl) phthalate; MEHP, mono(2-
ethylhexyl) phthalate; MEOHP, mono(2-ethyl-5-oxohexyl) phthalate.
aMetabolite of DEHP.
Table 3.Median age at puberty onset in boys and girls.
Puberty outcome n
Median
age at
onset (y)
Onset before start
of follow-up
(at 9 y of
age) [n (%)]
Onset before end of
follow-up (at 12.75 y
of age) [n (%)]
Girls
Thelarche (B2+ ) 178 9.22 69 (39) 178 (100)
Pubarche (PH2+ ) 176 10.31 35 (20) 176 (100)
Menarche 159 11.67 1 (1) 139 (87)
Boys
Gonadarche (G2+ ) 159 10.79 0 (0) 158 (99)
Pubarche (PH2+ ) 159 12.18 0 (0) 157 (99)
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BPA, and pubertal timing. Our results suggest that childhood
obesity is an effect modifier but not a mediator for some chemi-
cals. We hypothesized that HMW phthalates would lead to
greater obesity, which would, in turn, lead to earlier puberty in
girls. However, this was not what we observed. Despite being
associated with increased risk of obesity in this population
(Harley et al. 2017), most phthalates were associated with later
puberty in girls, and Paramed models found little evidence of
mediation. For example, MBzP and DEHP were associated
with later thelarche in all models, including unstratified models
controlling or not controlling for overweight/obese status and
models stratified by overweight/obesity. For these associations,
there is a significant natural direct effect but no significant natu-
ral indirect effect. However, these associations are stronger
in overweight girls and somewhat attenuated in nonstratified
models after controlling for 7-y-of-age overweight/obese sta-
tus, implying the possibility of a confounding factor in this
association that is related to obesity but not obesity itself.
There may be thelarche stage misclassification among the
heavier girls: Tanner staging of breast development is more prone
to error in overweight/obese girls because of the difficulty in differ-
entiating between mammary and adipose tissue, even with manual
palpation. If there were more measurement error in assessing
breast development in overweight/obese girls, this might artifi-
cially attenuate any associations with later thelarche in overweight
girls. However, we observed natural indirect effects that were
almost all very close to null, in contrast to many of the natural
direct effects, which were farther from the null and mostly indicat-
ing earlier puberty, again implying that obesity status is not a me-
diator in this relationship.
Table 4. Adjusted mean shift (in months) of age at pubertal onset associated with log2-increase in prenatal urinary biomarker concentrations in underweight/
normal-weight girls and overweight/obese girls.
Biomarker
All girls Normal weight Overweight/obese
pInteractionn Mean shift (95% CI) n Mean shift (95% CI) n Mean shift (95% CI)
Thelarche (B2+ )
MBzP 165 1.9 (0.2, 3.6) 83 1.6 (−0:3, 3.4) 81 3.9 (1.2, 6.7) 0.58
MCNP 165 1.2 (−0:6, 3.1) 83 1.4 (−0:5, 3.3) 81 2.0 (−1:2, 5.3) 0.63
MCOP 165 2.0 (0.0, 4.0) 83 1.4 (−0:4, 3.3) 81 3.2 (−0:2, 6.9) 0.53
MCPP 165 1.1 (−0:4, 2.7) 83 2.3 (0.1, 4.6) 81 0.5 (−1:6, 2.6) 0.30P
DEHP 165 2.5 (0.7, 4.3) 83 2.6 (0.8, 4.4) 81 4.9 (1.7, 8.2) 0.57
BPA 168 3.0 (0.9, 5.1) 84 4.7 (2.5, 7.0) 81 1.6 (−1:6, 4.8) 0.10
Pubarche (PH2+ )
MBzP 163 0.2 (−1:5, 1.9) 83 0.9 (−1:7, 3.5) 79 0.3 (−1:5, 2.2) 0.55
MCNP 163 0.2 (−1:5, 1.9) 83 2.0 (−0:1, 4.1) 79 −1:2 (−3:6, 1.3) 0.05
COP 163 1.6 (−0:2, 3.4) 83 2.4 (0.4, 4.5) 79 0.4 (−2:3, 3.3) 0.20
MCPP 163 0.3 (−1:6, 2.3) 83 2.0 (−0:8, 4.8) 79 − 0:4 (−2:5, 1.8) 0.14P
DEHP 163 1.4 (−0:3, 3.2) 83 2.0 (−0:3, 4.4) 79 1.7 (−0:6, 4.1) 0.62
BPA 166 1.2 (−0:9, 3.3) 84 4.0 (1.3, 6.7) 79 −1:2 (−3:8, 1.5) <0:01
Menarche
MBzP 165 0.7 (−0:6, 2.0) 83 0.8 (−1:2, 2.6) 81 0.9 (−0:9, 2.7) 0.73
MCNP 165 0.5 (−0:9, 2.0) 83 2.4 (0.4, 4.3) 81 −0:3 (−2:4, 1.9) 0.06
MCOP 165 1.2 (−0:3, 2.8) 83 2.1 (0.1, 4.2) 81 0.8 (−1:7, 3.3) 0.24
MCPP 165 0.9 (−0:3, 2.0) 83 3.3 (1.3, 5.4) 81 0.1 (−1:3, 1.7) 0.01P
DEHP 165 2.5 (1.1, 4.1) 83 2.7 (0.7, 4.6) 81 3.2 (0.9, 5.5) 0.96
BPA 169 1.0 (−0:6, 2.6) 84 3.2 (1.1, 5.3) 82 −0:6 (−2:9, 1.8) 0.02
Note: Biomarker concentrations are a specific gravity–adjusted average of measurements in two pregnancy urine samples. Accelerated failure time models adjusted for maternal educa-
tion, years in United States, family poverty during pregnancy, Diet Quality Index during Pregnancy, and maternal prepregnancy BMI. AFT, accelerated failure time; BMI, body mass
index; BPA, bisphenol A; CI, confidence interval; MBzP, monobenzyl phthalate; MCNP, monocarboxynonyl phthalate; MCOP, monocarboxyoctyl phthalate; MCPP, mono(3-carbox-
ypropyl) phthalate;
P
DEHP, summation of di(2-ethylhexyl) phthalate (DEHP). p-Values for interaction are for the interaction terms log2 biomarker concentrations × overweight=
obese status included in the AFT models.
Table 5. Adjusted mean shift (in months) of age at pubertal onset associated with log2 prenatal urinary biomarker concentrations in underweight/normal-weight
boys and overweight/obese boys.
Biomarker
All boys Normal weight Overweight/obese
pInteractionn Mean shift (95% CI) n Mean shift (95% CI) n Mean shift (95% CI)
Gonadarche (G2+ )
MBzP 148 −3:1 (−5:2, −0:9) 55 −0:9 (−4:2, 2.5) 89 −4:3 (−6:8, −1:8) 0.07
MCNP 148 −3:9 (−7:2, −0:6) 55 0.2 (−6:0, 6.7) 89 −4:8 (−8:3, −1:1) 0.03
MCOP 148 −3:2 (−6:1, −0:4) 55 0.3 (−5:3, 6.1) 89 −5:3 (−8:5, −1:9) 0.03
MCPP 148 −4:1 (−6:4, −1:7) 55 1.7 (−2:9, 6.4) 89 −6:7 (−9:4, −4:0) <0:01P
DEHP 148 −1:4 (−4:2, 1.3) 55 1.1 (−2:2, 4.5) 89 −6:3 (−10:7, −1:8) <0:01
BPA 147 −4:1 (−6:6, −1:6) 55 −5:0 (−9:1, −0:6) 88 −5:2 (−8:1, −2:2) 0.35
Pubarche (PH2+ )
MBzP 148 −1:3 (−3:1, 0.4) 55 3.5 (0.4, 6.5) 89 −3:6 (−5:7, −1:4) <0:01
MCNP 148 −2:4 (−5:0, 0.3) 55 4.4 (−1:0, 10.1) 89 −3:9 (−6:6, −1:1) 0.06
MCOP 148 −2:4 (−4:6, −0:3) 55 2.3 (−1:9, 4.4) 89 −3:4 (−5:6, −1:3) 0.13
MCPP 148 −2:0 (−3:8, −0:1) 55 0.5 (−2:6, 3.7) 89 −3:1 (−5:2, −1:0) 0.01P
DEHP 148 −1:9 (−4:1, 0.3) 55 1.1 (−1:7, 4.1) 89 −3:8 (−6:7, −0:7) 0.03
BPA 147 −3:1 (−5:1, −1:0) 55 −2:0 (−5:9, 1) 88 −3:9 (−6:0, −1:8) 0.01
Note: Biomarker concentrations are a specific gravity–adjusted average of measurements at the baseline and 26-week visits. Accelerated failure time models adjusted for maternal edu-
cation, years in United States, family poverty during pregnancy, Diet Quality Index during Pregnancy, and maternal prepregnancy BMI. AFT, accelerated failure time; BMI, body
mass index; BPA, bisphenol A; CI, confidence interval; MBzP, monobenzyl phthalate; MCNP, monocarboxynonyl phthalate; MCOP, monocarboxyoctyl phthalate; MCPP, mono(3-
carboxypropyl) phthalate; MEHP, mono(2-ethylhexyl) phthalate;
P
DEHP, summation of di(2-ethylhexyl) phthalate (DEHP). p-Values for interaction are for the interaction terms
log2 biomarker concentrations × overweight=obese status included in the AFT models.
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Child weight also appears to be an effect modifier but not a
mediator in the associations between BPA and puberty timing
in girls. In thelarche, pubarche, and menarche, BPA is associ-
ated with later timing in normal-weight girls only and does not
show any significant natural direct or indirect effects. Because
BPA is associated with lower obesity in this population
(Harley et al. 2013), we would expect BPA to be associated
with later pubertal timing if obesity were a mediator in these
relationships.
The association of BMI and puberty in boys is less clear than
in girls (Burt Solorzano and McCartney 2010). It is possible that
phthalate exposure is associated with increased risk of obesity,
which in turn leads to earlier puberty, or that there may be a sub-
group of boys for whom in utero phthalate exposure leads to both
childhood obesity and earlier puberty onset, which could explain
why the associations were only seen in this group. The conflicting
results of attenuated associations after adjusting for obesity, but
without any indirect effects, again implies that obesity is an effect
modifier but not a mediator and suggests that there is a confound-
ing factor in this relationship that is strongly related to obesity
but is not obesity itself.
One explanation for our results is that stratifying by BMI opens
a backdoor path to a confounder that affects both childhood BMI
and timing of puberty (Banack and Kaufman 2014). We were
unable to control for all potential confounders that fall under this
category, but this possibility should be kept in mind when inter-
preting our results. Additionally, our data may not have met all the
assumptions required for mediation analysis. We believe we have
controlled for potential confounding between our exposures and
outcomes, mediator and outcomes, and exposures and mediator,
and we believe none of the mediator–outcome confounders were
affected by the exposures. However, our mediation results should
be interpreted with the consideration that we may not have con-
trolled for all confounding.
In addition to the high prevalence of obesity, our population
differed significantly from other studies. Our population was
largely Mexican American from a farm-working community,
most with a family income under 100% of the federal poverty
level and low maternal education level. Although this makes our
population somewhat comparable to that of the Mexico City
ELEMENT study, the only other study to examine in utero expo-
sure, our results may not be generalizable to all populations.
There were several limitations to the current study. Phthalates
(Frederiksen et al. 2007) and BPA (Vandenberg et al. 2007) are
rapidly metabolized within the body, which may render two uri-
nary measurements during pregnancy inadequate to represent
overall urinary concentrations. However, single measurements of
these chemicals have been shown to be relatively consistent over
time (Teitelbaum et al. 2008). Concentrations of these chemicals
were moderately to highly correlated in our population, so esti-
mates for one chemical may be confounded by correlated concen-
trations of another chemical. We did not begin evaluating children
for puberty milestones until 9 y of age, by which time several chil-
dren, particularly girls, had already begun puberty. This left cen-
soring may bias time ratio measures toward the null. We also
evaluated children at 9-month intervals, so all puberty measure-
ments are interval censored. The time ratio models, however, allow
for interval- and right-censored data. In addition, it is more difficult
to detect thelarche in overweight girls as explained above, and
many of our girls were overweight or obese.
This study also has notable strengths. It is one of only a few
studies to date that has included urinary biomarker concentrations
during the critical window of pregnancy. We measured concen-
trations twice to get a more accurate picture of prenatal exposure
and assessed pubertal status at six time points across relevant
ages to gauge onset of puberty as accurately as possible; we also
selected statistical methods that allowed for interval censoring. In
additional, because over half of our study population was over-
weight or obese, we had power to assess interactions with over-
weight/obese status.
Conclusions
We found evidence that in utero exposure to HMW phthalates
and BPA was associated with later onset of puberty in girls, par-
ticularly normal-weight girls, and with earlier onset of puberty in
boys, particularly overweight/obese boys, in our study popula-
tion. Although this is contrary to the hypothesis that these bio-
markers would be related to earlier puberty in girls rather than
delayed puberty because exposures to these chemicals and early
onset female puberty have increased in recent decades, our results
provide additional evidence that these chemicals may modify
pubertal timing in children. Future research should focus on
high-quality longitudinal measurements of pubertal timing and
prenatal and early life exposure measurements and should further
explore the potentially modifying effect of overweight/obese
status.
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